期刊文献+

VX2乳腺癌兔的阿霉素致心脏毒性模型的建立 被引量:3

The establishment of adriamycin-induced cardiactoxicity model in rabbit xenograft model of breast cancer VX2
下载PDF
导出
摘要 目的建立VX2乳腺癌兔的阿霉素致的心脏毒性模型。方法先建立兔VX2乳腺癌模型。2周后,将接种VX2乳腺癌成功模型兔随机分为阿霉素(ADR)组和对照组,阿霉素组10只,雌雄各5只,对照组8只,雌雄各4只。ADR组,每周1次于兔耳缘静脉注射ADR(用生理盐水配制成1mg/ml)2mg/kg,共6次。对照组,每周1次于耳缘静脉推注生理盐水每次2ml/kg,共6次。比较左心室射血分数的变化,并作心脏和肿块的病理切片,观察其组织学变化,记录动物的生存时间。结果模型成功率为90%,两组左心室射血分数(LVEF)差异有统计学意义(P<0.05),阿霉素组的心脏经病理检查证实为有心肌病变,病理学结果证实符合心肌病样改变,肿块经病理检验证实为鳞状细胞癌。结论成功建立了VX2乳腺癌兔的阿霉素致心脏毒性模型。 Objective To establish adriamycin-induced Cardiactoxicity model in rabbit Xenograft Model of Breast Cancer VX2. Methods To establish Xenograft Model of Breast Cancer VX2 in rabbit. After 2 weeks,The rabbits with VX2 breast carcinoma were randomly divided into the Adriamycin treatment group (10 cases)and the control group (8 cases). The Treatment group was given Adriamycin 2 mg/kg every week into auricular vein of ears for consecutive 6 weeks after the first injection. The control group was given normal saline respectively. The Changes of left ventricular ejection fraction(LVEF) were compared between the two groups. Hearts and Tumors were harvested after that and analyzed by histological staining. Tumor-bearing survival time was recorded. Results The successful rate of the model group was 90. There was a significant difference in LVEF% between the two groups ( P 〈 0. 05 ). Pathological examination demonstrated that the cardiac muscular tissue of the model group were harmed, which characteristic cconsistent with cardiomyopathy. Tumors were conformaed to the feature of squamous cell carcinoma . Conclusion Adriamycin-induced Cardiactoxicity model in rabbit Xenograft Model of Breast Cancer VX2, which would provide a considerable aninel model for investigation of clinic ,was established successfully.
出处 《中国现代药物应用》 2008年第9期5-7,共3页 Chinese Journal of Modern Drug Application
关键词 移植性肿瘤 阿霉素 心脏毒性 模型 Xenograft Adriamycin Cardiactoxicity Model
  • 相关文献

参考文献3

二级参考文献40

  • 1Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents:incidence, treatment and prevention. Drug Saf, 2000,22 (4):263-302.
  • 2Duquaine D, Hirsch GA, Chakrabarti A, et al. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase. Vasc Med, 2003,8 (2) : 101-107.
  • 3Li T, Singal PK. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol.Circulation, 2000,102(17):2105-2110.
  • 4Wang S, Konorev EA, Kotamraju S, et al. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms, intermediacy of H (2) O (2)- and p53-dependent pathways. J Biol Chem, 2004, 279(24):25535-25543.
  • 5Sawyer DB, Fukazawa R, Arstall MA, et al. Daunorubicininduced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ Res, 1999, 84(3):257-265.
  • 6Minotti G, Recalcati S, Mordente A, et al. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J, 1998, 12(7):541-552.
  • 7Estevez MD, Wolf A, Schramm U. Effect of PSC 833, verapamil and amiodarone on adriamycin toxicity in cultured rat cardiomyocytes. Toxicol In Vitro, 2000,14 ( 1 ) : 17-23.
  • 8Weilbach FX, Chan A, Toyka KV, et al. The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis. Clin Exp Immunol,2004,135(1):49-55.
  • 9Von Hoff DD, Layard MW, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med,1979,91(5) :710-717.
  • 10Safra T. Cardiac safety of liposomal anthracyclines. Oncologist,2003, 8(2):17-24.

共引文献48

同被引文献38

  • 1张仲林,彭成.基因芯片技术在中医药研究领域中的应用[J].中国药科大学学报,2007,38(2):190-192. 被引量:8
  • 2李明华,赵德华,张贵卿.马钱子碱对豚鼠心脏乳头肌动作电位的影响[J].中国药理学通报,1997,13(2):157-159. 被引量:20
  • 3Yamashita K,Shimizu K.Video-assisted breast surgery and sentinel lymph node biopsy guided by three-dimensional computed tomographic lymphography[J].Surg Endosc,2008,22:392-397.
  • 4Guermazi A,Brice P,Hennequin C,et al.Lymphography:an old technique retains its usefulness[J].Radiographics,2003,23:1541-1558.
  • 5Ali Guermazi, Pauline Brice, Christophe Hennequin, et al. Lymphography: An Old Technique Retains Its Usefulness[J]. Radiographics, 2003, 23: 1541-1558.
  • 6K. Yamashita, K. Shimizu. Video-assisted breast surgery and sentinel lymph node biopsy guided by three-dimensional eomputed tomographic lymphography [J]. Surg Endosc, 2008, 22:392 -397.
  • 7J Robert. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: Predictiveness and pitfalls [ J ]. Cell Biol Toxicol, 2007,23 : 27-37.
  • 8Van Dartel DAM, Pennings JLA, Robinson JF, et al. Discriminating classes of developmental toxicants usinggene expression profiling in the embryonic stem cell test [ J ]. Toxicol Lett, 2011,201 ( 2 ) : 143-151.
  • 9Evans MJ, KaufmanMH. Establishment in culture of pluripotential cell from mouse embryos [ J ]. Nature, 1981 ,292(5819) :154-156.
  • 10Thomson JA, Itskovitz E J, Shapiro SS , et al. Embryonic Stem Cell line derived from human blastocysts [ J ]. Science, 1998,282 ( 5391 ) : 1145-1147.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部